Biomarkers for insulin sensitizer drug response

Details for Australian Patent Application No. 2009325962 (hide)

Owner IKFE GmbH

Inventors Pfuetzner, Andreas

Agent Davies Collison Cave

Pub. Number AU-A-2009325962

PCT Pub. Number WO2010/067207

Priority 61/121,754 11.12.08 US; 61/254,129 22.10.09 US

Filing date 11 December 2009

Wipo publication date 17 June 2010

International Classifications

G01N 33/68 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

28 July 2011 PCT application entered the National Phase

  PCT publication WO2010/067207 Priority application(s): WO2010/067207

15 December 2011 Alteration of Name

  The name of the applicant has been altered to IKFE Institut fur klinische Forschung und Entwicklung GmbH 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009325971-Nanofibers having embedded particles

2009325950-IgE CH3 peptide vaccine